HUYA Bioscience International Announces Strategic Collaboration With the Shenyang Pharmaceutical University
SAN DIEGO, June 8 /PRNewswire/ -- HUYA Bioscience International, a leader in enabling and accelerating the global co-development of novel biopharmaceutical product opportunities originating in China, today announced a strategic drug co-development partnership with the Shenyang Pharmaceutical University. The agreement covers a wide range of therapeutic areas and represents one of the first official collaborations of its kind between a U.S. biotech company and a Chinese university.
HUYA is one of the first companies to have recognized China's potential to help meet the global need for new pre-clinical and clinical stage compounds. The agreement with Shenyang Pharmaceutical University provides HUYA with rights of first review and negotiation relating to certain novel therapeutic compounds owned or controlled by the University. In return, Shenyang Pharmaceutical University gains access to HUYA's global network of pharmaceutical partners and its expertise in pre-clinical and clinical development.
"Shenyang Pharmaceutical University is a leading pharmaceutical institution with a tradition of innovation," said Mireille Gingras, PhD, President and CEO of HUYA. "We are enthusiastic about collaborating with this University to develop new products for global markets."
Enhancing its collaboration with Shenyang Pharmaceutical University, HUYA has key partnerships with leading global pharmaceutical companies such as Solvay Pharmaceuticals, Abbott, and Schering-Plough. By establishing an extensive global network and world-class drug development capabilities HUYA has become the partner-of-choice for Chinese institutions, universities and biopharma companies looking to maximize the value of their pre-clinical and clinical stage drugs for global markets. HUYA has acquired the development and commercialization rights to two novel development stage drug candidates sourced from China and is developing these candidates in the U.S. for cardiovascular and oncology indications.
"Through our partnership with HUYA, Shenyang Pharmaceutical University looks forward to expanding our international collaborations and gaining broader access to the worldwide markets for our innovative products," said Dr. Shunkai Bi, Vice President of Shenyang Pharmaceutical University.
About HUYA Bioscience International
HUYA Bioscience International is a leader in enabling and accelerating the global co-development of novel biopharmaceutical product opportunities originating in China. HUYA has established extensive collaborations with Chinese academic and commercial biopharmaceutical organizations to enhance development efficiency and value creation in world-wide markets for China-sourced product candidates. With the largest Chinese compound portfolio covering all therapeutic areas, HUYA has emerged as the partner-of-choice for building and maximizing the worldwide value of biopharmaceutical innovation in China. HUYA is jointly headquartered in San Diego, CA, and Shanghai, PRC. Additional information about the company is available at www.huyabio.com.
About Shenyang Pharmaceutical University
The Shenyang Pharmaceutical University has the longest tradition among China's pharmaceutical universities. It was founded in 1931, and now has over 260 professors and associate professors, over a quarter of who are overseas returnees. It is a national leader in the synthesis and screening of novel pharmaceutical compounds, pharmaceutical formulation development and evaluation, pharmacokinetics and pharmacodynamics, pharmacology and toxicology, and identification and purification of active ingredients from Traditional Chinese Medicines and natural products.
CONTACT: USA, Bob Giargiari, EVP Finance and CFO, +1-858-798-8800,
firstname.lastname@example.org, or China, Li Zhu, PhD, VP China Operations, 86 (21)
51323312, email@example.com, both of HUYA Bioscience International, LLC; or
Media, Juliet Travis, +1-510-452-3771, firstname.lastname@example.org, for HUYA
Bioscience International, LLC
Web site: http://www.huyabio.com/